Ayanoglou John 4

Accession 0001493152-23-007404

CIK 0001630113other

View on SEC.gov Company Profile

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 4:10 PM ET

Size

49.6 KB

Accession

0001493152-23-007404

Insider Transaction Report

Form 4

Period: 2017-10-26

BIOTRICITY INC.BTCY

Ayanoglou John

Chief Financial Officer

Transactions

Award
Warrants
2017-10-26+50,000→ 50,000 total
Exercise: $0.73Exp: 2030-12-31→ Common Stock (50,000 underlying)
Award
Warrants
2018-03-31+50,000→ 100,000 total
Exercise: $0.73Exp: 2030-12-31→ Common Stock (50,000 underlying)
Award
Warrants
2018-06-30+50,000→ 150,000 total
Exercise: $0.73Exp: 2030-12-31→ Common Stock (50,000 underlying)
Award
Warrants
2021-09-30+50,000→ 850,000 total
Exercise: $2.40Exp: 2031-09-30→ Common Stock (50,000 underlying)
Award
Warrants
2022-09-30+118,282→ 1,109,703 total
Exercise: $0.80Exp: 2032-09-30→ Common Stock (118,282 underlying)
Award
Warrants
2022-12-31+218,785→ 1,328,488 total
Exercise: $0.45Exp: 2032-12-30→ Common Stock (218,785 underlying)
Award
Warrants
2018-12-31+50,000→ 250,000 total
Exercise: $0.48Exp: 2028-12-30→ Common Stock (50,000 underlying)
Award
Warrants
2019-03-31+50,000→ 300,000 total
Exercise: $0.91Exp: 2029-03-30→ Common Stock (50,000 underlying)
Award
Warrants
2019-06-30+50,000→ 350,000 total
Exercise: $0.66Exp: 2029-06-29→ Common Stock (50,000 underlying)
Award
Warrants
2019-09-30+50,000→ 400,000 total
Exercise: $0.58Exp: 2029-09-29→ Common Stock (50,000 underlying)
Award
Warrants
2019-12-31+50,000→ 450,000 total
Exercise: $0.63Exp: 2029-12-30→ Common Stock (50,000 underlying)
Award
Warrants
2020-03-31+50,000→ 500,000 total
Exercise: $0.97Exp: 2030-03-31→ Common Stock (50,000 underlying)
Award
Warrants
2020-06-30+50,000→ 550,000 total
Exercise: $1.37Exp: 2030-06-30→ Common Stock (50,000 underlying)
Award
Warrants
2020-09-30+50,000→ 600,000 total
Exercise: $1.11Exp: 2030-09-30→ Common Stock (50,000 underlying)
Award
Warrants
2021-03-31+50,000→ 750,000 total
Exercise: $2.40Exp: 2031-03-31→ Common Stock (50,000 underlying)
Award
Warrants
2021-12-31+50,000→ 900,000 total
Exercise: $2.40Exp: 2031-12-31→ Common Stock (50,000 underlying)
Award
Warrants
2022-06-30+53,827→ 991,421 total
Exercise: $1.77Exp: 2032-06-30→ Common Stock (53,827 underlying)
Award
Warrants
2021-06-30+50,000→ 800,000 total
Exercise: $2.40Exp: 2031-06-30→ Common Stock (50,000 underlying)
Award
Warrants
2022-03-31+37,594→ 937,594 total
Exercise: $2.27Exp: 2032-03-31→ Common Stock (37,594 underlying)
Award
Warrants
2018-09-30+50,000→ 200,000 total
Exercise: $0.73Exp: 2030-12-31→ Common Stock (50,000 underlying)
Award
Warrants
2020-01-24+50,000→ 650,000 total
Exercise: $0.75Exp: 2030-01-23→ Common Stock (50,000 underlying)
Award
Warrants
2020-12-31+50,000→ 700,000 total
Exercise: $0.74Exp: 2030-12-31→ Common Stock (50,000 underlying)

Footnotes (1)

[F1]The Warrants were issued to the Reporting Person as a consideration for his services to the Issuer and are immediately exercisable.

Documents

1 file

4
ownership.xmlPrimary

Issuer

BIOTRICITY INC.

CIK 0001630113

→

Entity typeother

Related Parties

filerCIK 0001783723

Filing Metadata

Form type: 4
Filed: Mar 12, 8:00 PM ET
Accepted: Mar 13, 4:10 PM ET
Size: 49.6 KB

View on SEC.gov